Patent Validity Issue Underpins High Court Pay-For-Delay Case
The U.S. Supreme Court has finally decided to examine a long-running antitrust battle between the pharmaceutical industry and the Federal Trade Commission over so-called pay-for-delay settlements, clearing the way for the...To view the full article, register now.
Already a subscriber? Click here to view full article